Integration of bioinformatics and machine learning strategies identifies APM-related gene signatures to predict clinical outcomes and therapeutic responses for breast cancer patients
Published 2023 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Integration of bioinformatics and machine learning strategies identifies APM-related gene signatures to predict clinical outcomes and therapeutic responses for breast cancer patients
Authors
Keywords
-
Journal
NEOPLASIA
Volume 45, Issue -, Pages 100942
Publisher
Elsevier BV
Online
2023-10-14
DOI
10.1016/j.neo.2023.100942
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Molecular subtyping of breast cancer intrinsic taxonomy with oligonucleotide microarray and NanoString nCounter
- (2021) Yen-Jen Chen et al. BIOSCIENCE REPORTS
- MiRNA-based model for predicting the TMB level in colon adenocarcinoma based on a LASSO logistic regression method
- (2021) Zhengtian Li et al. MEDICINE
- Establishment and Validation of an Individualized Cell Cycle Process-Related Gene Signature to Predict Cancer-Specific Survival in Patients with Bladder Cancer
- (2020) Run Shi et al. Cancers
- Cytotoxic CD4+ T Cells in Bladder Cancer—A New License to Kill
- (2020) Adrian G. Sacher et al. CANCER CELL
- Analysis of prognostic genes in the tumor microenvironment of lung adenocarcinoma
- (2020) Zhan-yu Xu et al. PeerJ
- De novo prediction of cancer-associated T cell receptors for noninvasive cancer detection
- (2020) Daria Beshnova et al. Science Translational Medicine
- POTN: A Human Leukocyte Antigen-A2 Immunogenic Peptides Screening Model and Its Applications in Tumor Antigens Prediction
- (2020) Qingqing Meng et al. Frontiers in Immunology
- Gene signature of antigen processing and presentation machinery predicts response to checkpoint blockade in non-small cell lung cancer (NSCLC) and melanoma
- (2020) Jeffrey C Thompson et al. Journal for ImmunoTherapy of Cancer
- Breast Cancer Risk and Insulin Resistance: Post Genome-Wide Gene–Environment Interaction Study Using a Random Survival Forest
- (2019) Su Yon Jung et al. CANCER RESEARCH
- Intratumoral Activity of the CXCR3 Chemokine System Is Required for the Efficacy of Anti-PD-1 Therapy
- (2019) Melvyn T. Chow et al. IMMUNITY
- Expression of MHC class I, HLA-A and HLA-B identifies immune-activated breast tumors with favorable outcome
- (2019) María del Mar Noblejas-López et al. OncoImmunology
- Global, Regional, and National Cancer Incidence, Mortality, Years of Life Lost, Years Lived With Disability, and Disability-Adjusted Life-Years for 29 Cancer Groups, 1990 to 2017
- (2019) et al. JAMA Oncology
- HLA Heterozygote Advantage against HIV-1 Is Driven by Quantitative and Qualitative Differences in HLA Allele-Specific Peptide Presentation
- (2019) Jatin Arora et al. MOLECULAR BIOLOGY AND EVOLUTION
- Antigen presentation and tumor immunogenicity in cancer immunotherapy response prediction
- (2019) Shixiang Wang et al. eLife
- Targeting the TIGIT-PVR immune checkpoint axis as novel therapeutic option in breast cancer
- (2019) Hauke Stamm et al. OncoImmunology
- Development of a membrane lipid metabolism–based signature to predict overall survival for personalized medicine in ccRCC patients
- (2019) Maode Bao et al. EPMA Journal
- Defective HLA class I antigen processing machinery in cancer
- (2018) Lei Cai et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Targeting immune checkpoints potentiates immunoediting and changes the dynamics of tumor evolution
- (2018) Mirjana Efremova et al. Nature Communications
- Signatures of T cell dysfunction and exclusion predict cancer immunotherapy response
- (2018) Peng Jiang et al. NATURE MEDICINE
- Acquired cancer resistance to combination immunotherapy from transcriptional loss of class I HLA
- (2018) K. G. Paulson et al. Nature Communications
- Evaluating biological activity of compounds by transcription factor activity profiling
- (2018) Alexander Medvedev et al. Science Advances
- Identification and validation of novel microenvironment-based immune molecular subgroups of head and neck squamous cell carcinoma: implications for immunotherapy
- (2018) Y -P Chen et al. ANNALS OF ONCOLOGY
- Maftools: efficient and comprehensive analysis of somatic variants in cancer
- (2018) Anand Mayakonda et al. GENOME RESEARCH
- Atezolizumab and Nab-Paclitaxel in Advanced Triple-Negative Breast Cancer
- (2018) Peter Schmid et al. NEW ENGLAND JOURNAL OF MEDICINE
- High PD-L1 Expression Is Closely Associated With Tumor-Infiltrating Lymphocytes and Leads to Good Clinical Outcomes in Chinese Triple Negative Breast Cancer Patients
- (2017) NiJiati AiErken et al. International Journal of Biological Sciences
- HLA-E-expressing pluripotent stem cells escape allogeneic responses and lysis by NK cells
- (2017) Germán G Gornalusse et al. NATURE BIOTECHNOLOGY
- Mutational and putative neoantigen load predict clinical benefit of adoptive T cell therapy in melanoma
- (2017) Martin Lauss et al. Nature Communications
- Mining expression and prognosis of topoisomerase isoforms in non-small-cell lung cancer by using Oncomine and Kaplan–Meier plotter
- (2017) Guo-Xin Hou et al. PLoS One
- Tumor-Specific T Cell Dysfunction Is a Dynamic Antigen-Driven Differentiation Program Initiated Early during Tumorigenesis
- (2016) Andrea Schietinger et al. IMMUNITY
- Mutations Associated with Acquired Resistance to PD-1 Blockade in Melanoma
- (2016) Jesse M. Zaretsky et al. NEW ENGLAND JOURNAL OF MEDICINE
- Targeting of topoisomerases for prognosis and drug resistance in ovarian cancer
- (2016) Yang Bai et al. Journal of Ovarian Research
- Molecular and Genetic Properties of Tumors Associated with Local Immune Cytolytic Activity
- (2015) Michael S. Rooney et al. CELL
- Eradication of Large Solid Tumors by Gene Therapy with a T-Cell Receptor Targeting a Single Cancer-Specific Point Mutation
- (2015) M. Leisegang et al. CLINICAL CANCER RESEARCH
- Immune checkpoint modulation: Rational design of combination strategies
- (2015) Dmitriy Zamarin et al. PHARMACOLOGY & THERAPEUTICS
- The evaluation of tumor-infiltrating lymphocytes (TILs) in breast cancer: recommendations by an International TILs Working Group 2014
- (2014) R. Salgado et al. ANNALS OF ONCOLOGY
- PD-L1 Expression in Triple-Negative Breast Cancer
- (2014) E. A. Mittendorf et al. Cancer Immunology Research
- GSVA: gene set variation analysis for microarray and RNA-Seq data
- (2013) Sonja Hänzelmann et al. BMC BIOINFORMATICS
- Correlating transcriptional networks to breast cancer survival: a large-scale coexpression analysis
- (2013) Colin Clarke et al. CARCINOGENESIS
- MHC Class I Antigen Processing and Presenting Machinery: Organization, Function, and Defects in Tumor Cells
- (2013) P. Leone et al. JNCI-Journal of the National Cancer Institute
- Signatures of mutational processes in human cancer
- (2013) Ludmil B. Alexandrov et al. NATURE
- Correlation of microarray-based breast cancer molecular subtypes and clinical outcomes: implications for treatment optimization
- (2011) Kuo-Jang Kao et al. BMC CANCER
- microRNA-Associated Progression Pathways and Potential Therapeutic Targets Identified by Integrated mRNA and microRNA Expression Profiling in Breast Cancer
- (2011) F. M. Buffa et al. CANCER RESEARCH
- DNA methylation profiling reveals a predominant immune component in breast cancers
- (2011) Sarah Dedeurwaerder et al. EMBO Molecular Medicine
- Relationship between HLA class I antigen processing machinery component expression and the clinicopathologic characteristics of bladder carcinomas
- (2009) Helen P. Cathro et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- WGCNA: an R package for weighted correlation network analysis
- (2008) Peter Langfelder et al. BMC BIOINFORMATICS
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started